norivane
NORIVANE SALEABILITY DIAGNOSTIC

Would your business withstand buyer scrutiny tomorrow?

A structured Β£497 diagnostic that shows where value would be discounted, delayed, or re-traded away in a live transaction.

Built for Β£1m–£25m founders who want optionality. Not reassurance.

One-off payment. Structured report delivered within 1–3 hours. Reviewed before release.

What the report includes

BUYER PSYCHOLOGY

How buyers underwrite risk

Buyers do not start with growth. They start with fragility.

  • Owner dependence becomes continuity risk.
  • Revenue concentration becomes volatility and leverage loss.
  • Weak financial discipline becomes credibility discount.
  • Thin systems become delay and re-trading.
  • Growth only matters when it is transferable and controlled.

The diagnostic mirrors this lens.


RISK ASSESSMENT FRAMEWORK

What we test

Owner Dependence
WHAT BUYERS PRICE

Decisions, relationships, number two autonomy, meeting follow-through.

WHAT GETS EXPOSED

Continuity risk; key-person discount; decision bottlenecks.

Commercial Concentration
WHAT BUYERS PRICE

Largest client risk, margin at risk, contract protection, pricing basis.

WHAT GETS EXPOSED

Volatility; leverage loss; concentration discount.

Financial Scrutiny Readiness
WHAT BUYERS PRICE

Speed, reconciliation, variance-to-action discipline, KPI consequence.

WHAT GETS EXPOSED

Credibility discount; diligence delay; re-trading.

Management Depth
WHAT BUYERS PRICE

Second layer, decision authority, initiative origin, accountability rhythm.

WHAT GETS EXPOSED

Delay; thin bench discount; transferability risk.

Systems & Data Integrity
WHAT BUYERS PRICE

CRM-to-cash traceability, evidence pack discipline, change control.

WHAT GETS EXPOSED

Diligence friction; thin systems discount.

See how your business measures up


WEIGHTED LENSES

The five lenses

Owner Dependence
30%
Commercial Concentration
20%
Financial Scrutiny Readiness
20%
Management Depth
15%
Systems & Data Integrity
15%

DELIVERABLES

What the report includes

  • Composite score and band
  • Saleability Confidence Index (SCI)
  • Top three buyer-priced risks
  • Contradictions flagged where answers do not align
  • 30-day and 90-day action priorities
  • Appendix with your Q&A snapshot

This is not a valuation. It is a buyer-style structural interpretation.


AUDIENCE

Who it is for

For

Established founder-led businesses seeking clarity on transferability and scrutiny exposure; before a process.

Not for

Startups. Owners looking for someone to implement changes on their behalf. Anyone wanting reassurance instead of scrutiny.


PROCESS

How it works

  1. 1Pay securely
  2. 2Complete the questionnaire
  3. 3Receive your structured report within 1–3 hours (reviewed before release)
  4. 4Owners who want to act on the findings can discuss a structured accountability programme.

WHO YOU'RE DEALING WITH

Who you're dealing with

In his thirties, Matthew Broadbent received an offer he couldn't refuse for his own business. Despite several transactions under his belt at Deloitte, and despite having employment contracts filed, reviewed T&Cs, forecasts, and management accounts all in order β€” he nearly missed it. His automation systems required him personally. His client relationships were in the wrong department for the buyer. The list went on.

He wasn't investment ready because he hadn't thought he'd be exiting.

That experience, combined with three decades as a Chartered Accountant across transactions, corporate finance, and operational leadership as MD and CEO across multiple businesses β€” and years as a fund manager underwriting SME deals from the buyer's side β€” is what the diagnostic is built on.

β€œOne of a rare breed who demonstrates not only a high level of financial expertise, but also a high degree of business acumen. He translates the financial aspects of running a business to both the strategic and tactical needs of the organisation. He consistently shows a great deal of insight and commitment.”

Managing Director, construction sector

β€œHard-won through years in boardrooms, high-stakes meetings, late-night document reviews, reading people acutely, and skilfully navigating conversations to uncover the truth. Time spent in Matthew's company is always an investment.”

Senior Technology Professional

β€œRobust financial analysis of investment opportunities, helpful strategic input, absolute integrity.”

Finance and Investment Director, property sector

FAQ

Frequently asked questions

What do I get?
A structured report with composite score, Saleability Confidence Index, top three buyer-priced risks, contradiction flags, and 30-day action priorities. Delivered within 1–3 hours. Reviewed before release. Not a valuation.
How long does it take?
The questionnaire takes around 25–40 minutes. The report is delivered within 1–3 hours. We review it before release.
Is this a valuation?
No. It is a buyer-style structural interpretation. It shows where value would be discounted or re-traded, not what your business is worth.
Who is it for?
Established founder-led businesses (Β£1m–£25m) seeking clarity on transferability and scrutiny exposure before a process. Not for startups or anyone wanting reassurance instead of scrutiny.
What if I disagree with the report?
The diagnostic mirrors how buyers underwrite risk. If answers align with stronger structures, the output reflects that. No appeals process; you are buying a structured scrutiny pass.

Run it before the market runs it for you

You are buying a structured scrutiny pass. It shows where a buyer would apply friction or discount. You see it early, while you still control timing.

One-off payment. Structured report delivered within 1–3 hours. Reviewed before release.

This is priced at Β£497 because you are buying the output of the experience, not access to it. The report is sharp, structured, and deliberately brief β€” every line has been earned through decades of transactions, operational leadership, and investing from the buyer's side. You get the lens without the hourly rate.